Bispecific Antibodies in the Management of Multiple Myeloma

From Oncology Today with Dr Neil Love Dr. Neil Love

Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma.

CME information and select publications here.

Community discussion

Join the conversation

Bispecific Antibodies in the Management of Multiple Myeloma

You May Also Like

Tommy Cullum's Let's Get Freaky

Dumma Människor

Real Ghost Stories Online

Vedanta Cast

Mundo Insólito Radio

This Week in Microbiology

The Grave Talks | Haunted, Paranormal & Supernatural

Head Shepherd

Accès au Marché Mondial des Dispositifs Médicaux

Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra